News
A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...
The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...
The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
In the world of wellness and dietary supplements, the focus on natural and effective solutions for weight management and overall health has never been greater. One intriguing product that has emerged ...
C-Dine 501516 emerges as a heralded, all-natural solution, positioned as a safe substitute for Cardarine GW501516. This alternative promises akin benefits to its predecessor sans adverse effects.
The biotech’s drug, Imcivree, has FDA approvals for two rare forms of obesity. Preliminary data from a pivotal test in yet another type position the drug to continue Rhythm’s pipeline-in-a ...
Pharmaceutical companies are responding with innovative formulations and dosage forms of iodine supplements tailored to different patient demographics and regional needs. This driver underscores the ...
A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results